TEVA-BROMAZEPAM 3 MG
BROMAZEPAM : 3 MG · DIN 02230584 · TEVA CANADA LIMITED
Health Canada status: MARKETED
What is TEVA-BROMAZEPAM?
TEVA-BROMAZEPAM 3 MG contains BROMAZEPAM : 3 MG. It is listed in the Health Canada Drug Product Database under DIN 02230584, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 29-May-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-BROMAZEPAM used for?
Teva - Bromazepam (bromazepam) is useful for the short – term, symptomatic relief of manifestations of excessive anxiety in patients with anxiety neurosis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02230584 |
|---|---|
| Brand name | TEVA-BROMAZEPAM |
| Generic / active ingredient | BROMAZEPAM : 3 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 3 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| ATC code | N05BA08 BROMAZEPAM |
| AHFS class | 28:24.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-May-2015 |
| Original market date | 1997-03-03 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code N05BA08 BROMAZEPAM. 4 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-BROMAZEPAM | 3 MG | TABLET | APOTEX INC | MARKETED | DIN 02177161 |
| APO-BROMAZEPAM | 6 MG | TABLET | APOTEX INC | MARKETED | DIN 02177188 |
| TEVA-BROMAZEPAM | 6 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02230585 |
| ALTI-BROMAZEPAM 1.5MG TABLETS | 1.5 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02167808 |
| ALTI-BROMAZEPAM 3MG TABLETS | 3 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02167816 |
| ALTI-BROMAZEPAM 6MG TABLETS | 6 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02167824 |
| APO-BROMAZEPAM | 1.5 MG | TABLET | APOTEX INC | DORMANT | DIN 02177153 |
| BROMAZEPAM | 1.5 MG | TABLET | APOTEX INC | APPROVED | DIN 02171856 |
| BROMAZEPAM | 3 MG | TABLET | APOTEX INC | APPROVED | DIN 02171864 |
| BROMAZEPAM | 6 MG | TABLET | APOTEX INC | APPROVED | DIN 02171872 |
Who else supplies BROMAZEPAM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BROMAZEPAM appears in 73 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.